Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

MDCO - Medicines Company

Previous close
84.9
0   0%

Share volume: 0
Last Updated: Fri 03 Jan 2020 06:00:00 AM CET
Pharmaceuticals: Other: 0%

PREVIOUS CLOSE
CHG
CHG%
$84.90
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
55%
Profitability 53%
Dept financing 25%
Liquidity 34%
Performance 70%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$84.90
P/E Ratio 
N/A
DAY RANGE
$84.90 - $84.90
EPS 
-$3.11
52 WEEK RANGE
$18.83 - $84.98
52 WEEK CHANGE
$338.08
MARKET CAP 
6.768 B
YIELD 
N/A
SHARES OUTSTANDING 
79.723 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$79,162,786
AVERAGE 10 VOLUME 
$3,108,738
AVERAGE 30 VOLUME 
$5,770,888
Company detail
CEO: Mark Timney
Region: US
Website: http://www.themedicinescompany.com
Employees: 62
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Pharmaceuticals: Other
Sector: Health Technology

The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.

Recent news